Ron Aldrich
Senior Director of Investor Relations
Replay available
PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call
PTC Therapeutics, Inc. (NASDAQ: PTCT) Q4 2023 earnings conference call, held 2024-02-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Matthew Klein
Chief Executive Officer
Eric Powles
Chief Business Officer
Kylie O'Keefe
Chief Commercial Officer
Pierre Gravier
Chief Financial Officer
Brooke Schuster
Analyst, William Blair
Rick Miller
Analyst, Cantor Fitzgerald
Eric Joseph
Analyst, J.P. Morgan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.672 Good day and thank you for standing by. Welcome to PTC fourth quarter 2023 00:00:05.672 -- 00:00:10.895 financial results. At this time, all participants are in a listen-only mode. 00:00:10.895 -- 00:00:14.777 After the speaker's presentation, there will be a question and answer session. 00:00:14.777 -- 00:00:19.819 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:19.819 -- 00:00:23.201 You will then hear a message advising your hand is raised. 00:00:23.201 -- 00:00:26.363 To withdraw your question, press star 11 again. 00:00:26.363 -- 00:00:30.958 Please note that today's conference is being recorded I would now like to pass the call 00:00:30.958 -- 00:00:36.700 over to the Senior Director of Investor Relations, Ron Aldrich. 00:00:37.802 -- 00:00:42.884 Good afternoon, and thank you for joining us today to discuss PTC Therapeutics' fourth 00:00:42.884 -- 00:00:48.087 quarter and full year 2023 corporate update and financial results. 00:00:48.087 -- 00:00:51.569 I'm joined today by our Chief Executive Officer, Dr. 00:00:51.569 -- 00:00:56.792 Matthew Klein, our Chief Business Officer, Eric Powles, our Chief 00:00:56.792 -- 00:01:03.487 Commercial Officer, Kylie O'Keefe, and our Chief Financial Officer, Pierre Gravier. 00:01:03.487 -- 00:01:08.849 Today's call will include forward-looking statements based on our current expectations. 00:01:08.849 -- 00:01:13.871 Please take a moment to review the slide posted on our investor relations website 00:01:13.871 -- 00:01:18.252 in conjunction with the call, which contains our forward-looking statements. 00:01:18.252 -- 00:01:22.854 Our actual results could materially differ from these forward-looking statements, as 00:01:22.854 -- 00:01:28.176 s...